Brain recordings during awake surgery aim to read patients' thoughts
NCT ID NCT07499479
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether speech can be decoded from brain activity recorded during awake brain tumor surgery. Twenty adult patients will have a special graphene electrode grid placed on their brain surface for up to two hours while they name pictures. Researchers will use machine learning to see if they can predict which picture the patient named from the brain signals alone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- INBRAIN Graphene Cortical Interface (high-density graphene ECoG grid)
- What this could lead to
- If successful, this could lead to better ways to map language areas during brain surgery, potentially improving surgical outcomes.
- What could go wrong
- This is a very early, small study (20 participants) focused on recording, not treatment. The decoding may not work as hoped, and results may not apply to other patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of neurosurgery Lariboisière hospital-APHP
Paris, Île-de-France Region, 75010, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells outsmart brain tumors?
- Digital tests may offer a new way to track brain health in tumor patients
- Mapping the hidden toll of brain radiation on young minds
- Scientists create detailed brain maps to protect language during surgery
- Brain wave decoding aims to shield memory during tumor surgery
- Could a cancer drug shrink recurrent brain tumors?